Episode

When the Boardroom Asks "Are We Okay?" | A Brand Spotlight at Infosecurity Europe 2026 with Ian Schenkel, VP Sales, EMEA & APAC of Intel 471

Podcast
The ITSPmagazine Podcast
Published
Jun 11, 2026
Duration seconds
993
Processing state
not_requested
Canonical source
https://itspradio.com/episodes/when-the-boardroom-asks-are-we-okay-a-brand-spotlight-at-infosecurity-europe-2026-with-ian-schenkel-vp-sales-emea-apac-of-intel-471-EjsiXk6x
Audio
https://chtbl.com/track/1CBDEF/afp-110348-injected.calisto.simplecastaudio.com/0310f993-fbb0-4fcc-b698-db9af99f73ca/episodes/07b6ad90-1079-433f-8864-3b595fa7e68e/audio/128/default.mp3?aid=rss_feed&awCollectionId=0310f993-fbb0-4fcc-b698-db9af99f73ca&awEpisodeId=07b6ad90-1079-433f-8864-3b595fa7e68e&feed=uHBB4m9X
JSON
/v1/public/podcasts/the-itspmagazine-podcast-938250/episodes/when-the-boardroom-asks-are-we-okay-a-brand-spotlight-at-infosecurity-europe-2026-with-ian-schenkel-vp-sales-emea-apac-of-intel-471
Markdown
/podcast/the-itspmagazine-podcast-938250/when-the-boardroom-asks-are-we-okay-a-brand-spotlight-at-infosecurity-europe-2026-with-ian-schenkel-vp-sales-emea-apac-of-intel-471.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/the-itspmagazine-podcast-938250/episodes/when-the-boardroom-asks-are-we-okay-a-brand-spotlight-at-infosecurity-europe-2026-with-ian-schenkel-vp-sales-emea-apac-of-intel-471/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/the-itspmagazine-podcast-938250/when-the-boardroom-asks-are-we-okay-a-brand-spotlight-at-infosecurity-europe-2026-with-ian-schenkel-vp-sales-emea-apac-of-intel-471.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

The boardroom has stopped accepting reassurance and started demanding evidence. Recorded on the show floor at Infosecurity Europe 2026, this conversation unpacks how threat intelligence answers the question every director is now asking, often before an attack has even formed.